Literature DB >> 8775237

Megadose methylprednisolone for Kasabach-Merritt syndrome.

S Ozsoylu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8775237     DOI： 10.1007/bf02075777

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN： 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  13 in total

1.  Megadose methylprednisolone for diffuse infantile haemangiomatosis.

Authors:  S Ozsoylu
Journal:  Eur J Pediatr       Date:  1992-05       Impact factor: 3.183

2.  Successful treatment of Kasabach-Merritt syndrome with pentoxifylline.

Authors:  Y de Prost; D Teillac; C Bodemer; O Enjolras; C Nihoul-Fekete; D de Prost
Journal:  J Am Acad Dermatol       Date:  1991-11       Impact factor: 11.527

3.  High doses of methylprednisolone for Kasabach-Merritt syndrome.

Authors:  S Ozsoylu
Journal:  J Pediatr       Date:  1991-10       Impact factor: 4.406

4.  High-dose intravenous methylprednisolone for Kasabach-Merritt syndrome.

Authors:  S Ozsoylu
Journal:  Am J Hematol       Date:  1989-07       Impact factor: 10.047

5.  Treatment of life-threatening infantile hemangiomas with vincristine.

Authors:  J Perez Payarols; J Pardo Masferrer; C Gomez Bellvert
Journal:  N Engl J Med       Date:  1995-07-06       Impact factor: 91.245

6.  Megadose methylprednisolone for Kasabach-Merritt syndrome.

Authors:  S Ozsoylu
Journal:  Pediatr Hematol Oncol       Date:  1993 Apr-Jun       Impact factor: 1.969

7.  Giant hemangioma with thrombocytopenia and osteolysis successfully treated with prednisone.

Authors:  N Sadan; I Horowitz; L Choc; S S Pikielny; B Wolach
Journal:  J Pediatr Orthop       Date:  1989 Jul-Aug       Impact factor: 2.324

8.  Serious childhood angiomas: unsuccessful alpha-2b interferon treatment. A report of four cases.

Authors:  D Teillac-Hamel; Y De Prost; C Bodemer; P Andry; O Enjolras; G Sebag; F Brunelle; P Hubert; C Nihoul-Fekete
Journal:  Br J Dermatol       Date:  1993-10       Impact factor: 9.302

9.  Successful management of an infant with a giant hemangioma of the retroperitoneum and Kasabach-Merritt syndrome with alpha-interferon.

Authors:  R M Hatley; H Sabio; C G Howell; F Flickinger; R A Parrish
Journal:  J Pediatr Surg       Date:  1993-10       Impact factor: 2.545

10.  Interferon alfa-2a therapy for life-threatening hemangiomas of infancy.

Authors:  R A Ezekowitz; J B Mulliken; J Folkman
Journal:  N Engl J Med       Date:  1992-05-28       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.